| pubmed-article:19880451 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19880451 | lifeskim:mentions | umls-concept:C0021853 | lld:lifeskim |
| pubmed-article:19880451 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:19880451 | lifeskim:mentions | umls-concept:C0008359 | lld:lifeskim |
| pubmed-article:19880451 | lifeskim:mentions | umls-concept:C0475463 | lld:lifeskim |
| pubmed-article:19880451 | lifeskim:mentions | umls-concept:C0020964 | lld:lifeskim |
| pubmed-article:19880451 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:19880451 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
| pubmed-article:19880451 | lifeskim:mentions | umls-concept:C2347662 | lld:lifeskim |
| pubmed-article:19880451 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:19880451 | pubmed:dateCreated | 2009-11-5 | lld:pubmed |
| pubmed-article:19880451 | pubmed:abstractText | We previously showed that oral immunization of mice with a rice-based vaccine expressing cholera toxin (CT) B subunit (MucoRice-CT-B) induced CT-specific immune responses with toxin-neutralizing activity in both systemic and mucosal compartments. In this study, we examined whether the vaccine can induce CT-specific Ab responses in nonhuman primates. Orally administered MucoRice-CT-B induced high levels of CT-neutralizing serum IgG Abs in the three cynomolgus macaques we immunized. Although the Ab level gradually decreased, detectable levels were maintained for at least 6 mo, and high titers were rapidly recovered after an oral booster dose of the rice-based vaccine. In contrast, no serum IgE Abs against rice storage protein were induced even after multiple immunizations. Additionally, before immunization the macaques harbored intestinal secretory IgA (SIgA) Abs that reacted with both CT and homologous heat-labile enterotoxin produced by enterotoxigenic Escherichia coli and had toxin-neutralizing activity. The SIgA Abs were present in macaques 1 mo to 29 years old, and the level was not enhanced after oral vaccination with MucoRice-CT-B or after subsequent oral administration of the native form of CT. These results show that oral MucoRice-CT-B can effectively induce CT-specific, neutralizing, serum IgG Ab responses even in the presence of pre-existing CT- and heat-labile enterotoxin-reactive intestinal SIgA Abs in nonhuman primates. | lld:pubmed |
| pubmed-article:19880451 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19880451 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19880451 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19880451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19880451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19880451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19880451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19880451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19880451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19880451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19880451 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19880451 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19880451 | pubmed:issn | 1550-6606 | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:KiyonoHiroshi... | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:TeraoKeijiK | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:KatakaiYukoY | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:SasakawaChihi... | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:OnoFumikoF | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:TakaiwaFumioF | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:MimuroHitomiH | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:TakahashiYuko... | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:YukiYoshikazu... | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:ShibataHiroak... | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:TokuharaDaisu... | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:NochiTomonori... | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:MejimaMioM | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:NakanishiUshi... | lld:pubmed |
| pubmed-article:19880451 | pubmed:author | pubmed-author:KurokawaShiho... | lld:pubmed |
| pubmed-article:19880451 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19880451 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:19880451 | pubmed:volume | 183 | lld:pubmed |
| pubmed-article:19880451 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19880451 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19880451 | pubmed:pagination | 6538-44 | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:meshHeading | pubmed-meshheading:19880451... | lld:pubmed |
| pubmed-article:19880451 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19880451 | pubmed:articleTitle | A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity. | lld:pubmed |
| pubmed-article:19880451 | pubmed:affiliation | Division of Mucosal Immunology, Department of Microbiology and Immunology, University of Tokyo, Japan. | lld:pubmed |
| pubmed-article:19880451 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19880451 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
